Elizabeth De Gaspari is a research scientist at the Immunology Center of Adolfo Lutz Institute and a professor in the graduate program Interunits in Biotechnology, of University of São Paulo, both located in São Paulo, SP, Brazil. She has a Master's degree (1983) in Microbiology and Immunology from the Federal University of São Paulo (São Paulo, SP). She obtained her Ph.D (1990) in Immunology from the University of São Paulo (São Paulo, SP) and was a post-doctoral fellow (1992) at the Walter Reed Army Institute of Research (Washington, DC, USA). She has collaborated with different institutions abroad. She has experience in Immunology, with emphasis on the following topics: neonatal immunology, maternal-fetal interaction, mucosal immunology, adjuvants, and monoclonal antibodies. Her studies mainly focus on Neisseria meningitidis, but currently, she is also studying immune response and vaccine platforms for SARS-CoV-2. She has received awards from the Bill and Melinda Gates Foundation for studying DDA-BF as an adjuvant in bacterium vaccines formulations.